dc.contributor.author |
KATGI, ABDULLAH
|
|
dc.contributor.author |
KAHRAMAN, SELDA
|
|
dc.contributor.author |
ATACA, PINAR
|
|
dc.contributor.author |
PİŞKİN, ÖZDEN
|
|
dc.contributor.author |
ÖZCAN, MEHMET ALİ
|
|
dc.contributor.author |
ÖZSAN, GÜNER HAYRİ
|
|
dc.contributor.author |
DEMİRKAN, FATİH
|
|
dc.contributor.author |
ÜNDAR, BÜLENT
|
|
dc.date.accessioned |
2015-10-08T15:57:08Z |
NULL |
dc.date.available |
2015-10-08T15:57:08Z |
NULL |
dc.date.issued |
2011 |
|
dc.identifier.uri |
http://hdl.handle.net/20.500.12397/3664 |
NULL |
dc.description.abstract |
Malign plevral effüzyon, multiple myelomda progresyonla karekterize ve geç gelişenbir komplikasyondur. Tanıdan sonra ortalama yaşam süresi 4 aydır ve sistemikkemoterapilere oldukça dirençlidir. Biz bu makalede 49 yaşında tanıdan 4 ay sonramalign plevral effüzyon gelişen ve solunum yetmezliği nedeniyle kaybedilen birhastayı sunuyoruz.Malign pleural effusion is a late and rare complication of multiple myeloma revealingthe progression. The mean survival time is four months after the diagnosis with a poorresponse to systemic chemotherapy.In this paper we mentioned about a 49 year old multiple myeloma patient in her fourthmonth of the diagnosis with a formation of malign pleural effusion just after inductionchemotherapy and died because of respiratory failure. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Dokuz Eylül Üniversitesi Tıp Fakültesi |
en_US |
dc.subject |
Multiple myelom, plevral effüzyonMultiple myeloma, Pleural effusion |
en_US |
dc.title |
Malign Pleural Effusion In A Patient With Multiple Myeloma |
en_US |
dc.title.alternative |
MULTİPLE MYELOMLU HASTADA GELİŞEN MALİGN PLEVRAL EFFÜZYON |
en_US |
dc.type |
Article |
en_US |